Publication | Closed Access

Arsenic trioxide is a novel agent for combination therapy to prolong heart allograft survival in allo-primed T cells transferred mice

Regenerative MedicineHeart Allograft SurvivalCell TherapyTransplantationXenotransplantationImmunologyCardiac RegenerationGraft SurvivalCombination TherapyCell TransplantationArsenic TrioxideImmunotherapyMedicineCell BiologyGraft Rejection